$275.19
2.18[0.80%]
At close: Apr 24
$275.19
0[0.00%]
PreMarket: 6:26PM EDT
Amgen Stock (NASDAQ:AMGN), Analyst Ratings, Price Targets, Predictions
Amgen Inc has a consensus price target of $271.59, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from UBS, TD Cowen, and Truist Securities on April 17, 2024, April 17, 2024, and April 12, 2024. With an average price target of $321.33 between UBS, TD Cowen, and Truist Securities, there's an implied 16.77% upside for Amgen Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
UBS
TD Cowen
Truist Securities
RBC Capital
Raymond James
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Amgen
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/17/2024 | AMGN | Buy Now | Amgen | $275.19 | 3.2% | UBS | Colin Bristow | $314 → $284 | Maintains | Neutral | Get Alert |
| 04/17/2024 | AMGN | Buy Now | Amgen | $275.19 | 30.82% | TD Cowen | Yaron Weber | $370 → $360 | Maintains | Buy | Get Alert |
| 04/12/2024 | AMGN | Buy Now | Amgen | $275.19 | 16.28% | Truist Securities | Robyn Karnauskas | $320 → $320 | Reiterates | Buy → Buy | Get Alert |
| 04/03/2024 | AMGN | Buy Now | Amgen | $275.19 | 19.55% | RBC Capital | Gregory Renza | → $329 | Reiterates | Outperform → Outperform | Get Alert |
| 03/28/2024 | AMGN | Buy Now | Amgen | $275.19 | — | Raymond James | Gary Nachman | — | Reinstates | → Market Perform | Get Alert |
| 02/08/2024 | AMGN | Buy Now | Amgen | $275.19 | 27.18% | Goldman Sachs | Salveen Richter | $313 → $350 | Maintains | Buy | Get Alert |
| 02/07/2024 | AMGN | Buy Now | Amgen | $275.19 | 1.02% | Morgan Stanley | Terence Flynn | $281 → $278 | Maintains | Equal-Weight | Get Alert |
| 02/07/2024 | AMGN | Buy Now | Amgen | $275.19 | 19.55% | RBC Capital | Gregory Renza | $303 → $329 | Maintains | Outperform | Get Alert |
| 02/07/2024 | AMGN | Buy Now | Amgen | $275.19 | 27.18% | Goldman Sachs | Salveen Richter | $313 → $350 | Maintains | Buy | Get Alert |
| 02/01/2024 | AMGN | Buy Now | Amgen | $275.19 | 27.18% | Oppenheimer | Jay Olson | → $350 | Reiterates | Outperform → Outperform | Get Alert |
| 01/29/2024 | AMGN | Buy Now | Amgen | $275.19 | 14.1% | UBS | Colin Bristow | $315 → $314 | Maintains | Neutral | Get Alert |
| 12/21/2023 | AMGN | Buy Now | Amgen | $275.19 | 16.28% | Daiwa Capital | Narumi Nakagiri | → $320 | Upgrade | Neutral → Buy | Get Alert |
| 12/19/2023 | AMGN | Buy Now | Amgen | $275.19 | 18.46% | BMO Capital | Evan David Seigerman | $286 → $326 | Upgrade | Market Perform → Outperform | Get Alert |
| 12/12/2023 | AMGN | Buy Now | Amgen | $275.19 | 9.02% | RBC Capital | Gregory Renza | $256 → $300 | Upgrade | Sector Perform → Outperform | Get Alert |
| 11/29/2023 | AMGN | Buy Now | Amgen | $275.19 | 16.28% | Truist Securities | Robyn Karnauskas | → $320 | Reiterates | Buy → Buy | Get Alert |
| 11/09/2023 | AMGN | Buy Now | Amgen | $275.19 | -12.79% | Deutsche Bank | James Shin | → $240 | Initiates | → Hold | Get Alert |
| 11/02/2023 | AMGN | Buy Now | Amgen | $275.19 | -6.97% | RBC Capital | Gregory Renza | $253 → $256 | Maintains | Sector Perform | Get Alert |
| 11/02/2023 | AMGN | Buy Now | Amgen | $275.19 | 16.28% | Truist Securities | Robyn Karnauskas | → $320 | Upgrade | Hold → Buy | Get Alert |
| 11/02/2023 | AMGN | Buy Now | Amgen | $275.19 | -2.61% | UBS | Colin Bristow | $272 → $268 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Amgen (AMGN)?
The latest price target for Amgen (NASDAQ: AMGN) was reported by UBS on April 17, 2024. The analyst firm set a price target for $284.00 expecting AMGN to rise to within 12 months (a possible 3.20% upside). 44 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Amgen (AMGN)?
The latest analyst rating for Amgen (NASDAQ: AMGN) was provided by UBS, and Amgen maintained their neutral rating.
When was the last upgrade for Amgen (AMGN)?
The last upgrade for Amgen Inc happened on December 21, 2023 when Daiwa Capital raised their price target to $320. Daiwa Capital previously had a neutral for Amgen Inc.
When was the last downgrade for Amgen (AMGN)?
The last downgrade for Amgen Inc happened on October 31, 2022 when Barclays changed their price target from N/A to $234 for Amgen Inc.
When is the next analyst rating going to be posted or updated for Amgen (AMGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amgen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amgen was filed on April 17, 2024 so you should expect the next rating to be made available sometime around April 17, 2025.
Is the Analyst Rating Amgen (AMGN) correct?
While ratings are subjective and will change, the latest Amgen (AMGN) rating was a maintained with a price target of $314.00 to $284.00. The current price Amgen (AMGN) is trading at is $275.19, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.